期刊文献+

腹腔镜与开腹左肝切除术的前瞻性对照研究 被引量:6

Comparision of laparoscopic and open left Iobectomy : a prospective controlled study
原文传递
导出
摘要 目的比较腹腔镜与开腹左肝切除术的疗效。方法前瞻性对照分析2010年5月至2011年6月哈尔滨医科大学附属第一医院92例行左肝切除术患者的临床资料。其中行腹腔镜下左肝切除术者42例(腹腔镜组),行开腹左肝切除术者50例(开腹组)。对比腹腔镜与开腹左肝切除术治疗左半肝肿瘤的优缺点。计量资料采用t检验,计数资料采用x2检验和Fisher确切概率法。结果腹腔镜组患者施行肝左外叶切除29例,左半肝切除13例;其中1例伤及肝中静脉中转开腹。开腹组患者施行肝左外叶部分切除33例,左半肝切除17例。腹腔镜组患者的手术切缘距肿瘤距离为(1.6±0.6)CIll,长于开腹组的(1.2±0.4)cm(t=3.81,P〈0.05)。但腹腔镜组患者的术中出血量为(158±89)ml,明显少于开腹组的(292±172)ml(t=4.56,P〈0.05)。腹腔镜组患者的术后镇痛时间、胃肠道功能恢复时间和住院时间分别为(1.2±0.3)d、(23±4)h、(7.5±2.8)d,明显短于开腹组的(2.0±1.1)d、(49±7)h、(11.3±4.2)d(t=4.57,21.31,5.00,P〈0.05)。腹腔镜组和开暖组患者术后第1天的AST、ALT较术前均有不同程度升高,但腹腔镜组升高的幅度较开腹组小(t=6.73,5.03,P〈0.05);并且开腹组术后盯明显比术前延长(k2.32,P〈0.05)。腹腔镜组患者术后并发症发生率为7%(3/41),住院费用为(2.5±0.7)万元,均较开腹组的8%(4/50)和(2.6±0.6)万元低,但差异无统计学意义(t=0.74,P〉0.05)。开腹组患者中有1例术后因急性肝功能衰竭导致MODS死亡。结论腹腔镜左肝切除术成功率高,安全可行,与开腹手术比较具有手术创伤小、恢复快、总体疗效显著等优点。 Objective To compare the efficacy of laparoscopic and open left lobectomy. Methods The clinical data of 92 patients who received left lobectomy at the First Affiliated Hospital of Harbin Medical University from May 2010 to June 2011 were retrospectively analyzed. Of the 92 patients, 42 received laparoscopie left lobectomy (laparoscopie group) and 50 received open left lobectomy (open group). The advantages and disadvantages between laparoscopic and open left lobectomy were compared. All data were analyzed using tile t test, chi-square test or by calculating the Fisher exact probability. Results Twenty-nine patients received left lateral lobectomy and 13 patients received left hemihepatectomy in the laparoscopie group. One patient was converted to the open group becaused of the injury of the middle hepatic vein. Thirty-three patients underwent left lateral lobectomy and 17 underwent left hemihepatectomy in the open group. The tumor-free resection margin of the laparoscopic group was ( 1.6±0.6) em, which was significantly longer than ( 1.2±0.4) cm of the open group (t =3.81, P 〈0.05 ). The volume of operative blood loss of the laparoseopie group was (158 ±89)ml, which was significantly smaller than (292± 172) ml of the open group ( t = 4.56, P 〈 0.05 ). The time of postoperative pain control, time to bowel function recovery and duration of hospital stay were ( 1.2±0.3 ) days, (23± 4) hours, (7.5 ±2.8 )days in the laparoseopic group, which were significantly shorter than (2.0±1.1 )days, (49 ±7 )hours, ( 11.3 ±4.2)days in the open group, respectively ( t = 4. 57, 21.31, 5.00, P 〈 0.05 ). The levels of aspartate arninotransferase (AST) and alanine aminotransferase (ALT) at postoperative (lay 1 were increased, while the increase of AST and ALT in the open group were greater than that in the laparoscopic group ( t = 6.73, 5.03, P 〈 0.05 ). The postoperative prothrombin time in the open group was significantly longer than that before operation ( t = 2.32, P 〈 0.05 ). The incidence of postoperative complications and total hospital costs were 7% (3/41) and (2.5±0.7) x 104 yuan in the laparoscopie group, which were lower than 8% (4/50) and (2.6 +0.6)×10^4 yuau in the open group, but no significant difference was observed ( t = 0.74, P 〉 0.05 ). One patient in the open group died of multi-organ dysfunction syndrome caused by acute hepatic failure. Conclusion Laparoscopic left lobectomy is safe and effective, and it has the advantages of small trauma, quick recovery of patients and significant overall efficacy when compared with open left lobectomy.
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2012年第3期252-255,共4页 Chinese Journal of Digestive Surgery
基金 黑龙江省高等学校科技创新团队支撑计划(2009TD06)
关键词 肝肿瘤 腹腔镜检查 肝切除术 Liver neoplasms Laparoscopy Hepatectomy
  • 相关文献

参考文献14

  • 1Reich H, McGlynn F, DeCaprio J, et al. Laparoscopic excision of benign liver lesions. Obstet Gynecol, 1991,78 (SPt 2) :956-958.
  • 2周伟平,孙志宏,吴孟超,陈汉,张柏和,郑成竹,沈炎明,仇明.经腹腔镜肝叶切除首例报道[J].肝胆外科杂志,1994,2(2):82-82. 被引量:184
  • 3Mala T, Edwin B, Rosseland AR, et al. Laparoscopic liver resection : experience of 53 procedures at a single center. J Hepatobiliary Pancreat Surg,2005, 12 (4) :298- 303.
  • 4Dulucq JL, Wintringer P, Stabilini C, et al. Laparoscopie liver resections: a single center experience. Surg Endosc, 2005, 19 (7) :886-891.
  • 5Farge O, Jagot P, Kirstetter P, et al. Prospective assessment of the safety and benefit of laparoscopic liver resections. J Hepatobiliary Pancreat Surg,2002,9 (2) :242-248.
  • 6Teramoto K, Kawamura T, Takamatsu S, et al. Laparoscopic and thoracoscopic approaches for the treatment of hepatocellular carcinoma. Am J Surg,2005,189 (4) :474-478.
  • 7Kazaryan AM, Pavlik Marangos I, Rosseland AR, et al. Laparoscopic liver resection for malignant and benign lesions: ten-year Norwegian single-center experience. Arch Surg, 2010, 145 ( 1 ) : 34-40.
  • 8Cho JY, Han HS, Yoon YS, et al. Outcomes of laparoscopic liver resection for lesions located in the tight side of the liver. Arch Surg,2009,144 ( 1 ) :25-29.
  • 9Nguyen KT, Marsh JW, Tsung A, et al. Comparative benefits of laparoscopic vs open hepatic resection : a critical appraisal. Arch Surg ,2011,146 (3) :348-356.
  • 10Jensen EH, Vickers SM. The maximally invasive hepatobiliary surgeon: A dying breed? : Comment on " Laparoscopic vs open hepatectomy for benign and malignant tumor". Arch Surg, 2010, 145(11) :1109-1118.

二级参考文献48

  • 1Xiao-Ping Chen Fa-Zu Qiu Zai-De Wu Bi-Xiang Zhang.Hepatectomy for huge hepatocellular carcinoma in 634 cases[J].World Journal of Gastroenterology,2006,12(29):4652-4655. 被引量:16
  • 2Faivre S,Rarmond E,Boucher E,et al.Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma:an open-label,muhiceatre,phase Ⅱ study.Lancet Oncol,2009,10(8):794-800.
  • 3Uematsu S,Higashi T,Nouso K,et al.Altered expression of vascular endothelial growth factor,fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.J Gastroenterol Hepato1,2005,20(4):583-588.
  • 4Park JW,Finn RS,Kim JS,et al.Phase Ⅱ,open-label study of brivanib as first-line therapy in patients with advanced hepatocellulas carcinoma.Clin Cancer Res,2011,17(7):1973-1983.
  • 5Toh H,CP,Carr BI,Knox JJ,et al.A phase Ⅱ study of ABT869 in advanced hepatocellular carcinoma(HCC):Interim analysis.ASCO 2009,May 29 to June 2,2009,Orlando[C].Chicago:ASCO,2009.
  • 6Abou-Alfa GK,Johnson P,Knox JJ,et al.Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma:a randomized trial.JAMA,2010,304(19):2154-2160.
  • 7Yau T,CP,Cheung FY,Lee AS,et al.Phase Ⅱ trial of sorafenib with capecitabine and oxaliplatin(SECOX)in patients with locally advanced or metastatic hepatocellular carcinoma.Joint ECCO 15-34th ESMO Multidisciplinary Congress,Septmber 19-23,2009[C].Berlin:European Journal of Cancer Supplements,2009.
  • 8Thomas MB,Morris JS,Chadha R,et al.Phase Ⅱ trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.J Clin Oncol,2009,27(6):843-850.
  • 9Kasapetis CS,Khambata-Ford S,Jonker DJ,et al.K-ras mutations and benefit from cetuximab in advanced colorectal cancer.N Engl J Med,2008,359(17):1757-1765.
  • 10Abou-Alfa GK,Letourneau R,Harker G,et al.Randomized phase Ⅲ study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.J ClinOncol,2006,24(27):4441-4447.

共引文献230

同被引文献85

  • 1朱江帆,Richard Nahouraii,Francesco Rubino,Vicken N Pamoukian,Michel Gagner.FACS.肝血流出道阻断后腹腔镜肝切除术[J].腹腔镜外科杂志,2001,6(3):129-132. 被引量:7
  • 2周伟平,孙志宏,吴孟超,陈汉,张柏和,郑成竹,沈炎明,仇明.经腹腔镜肝叶切除首例报道[J].肝胆外科杂志,1994,2(2):82-82. 被引量:184
  • 3刘荣,黄志强,周宁新,王刚.腹腔镜解剖性肝切除技术研究[J].肝胆外科杂志,2005,13(2):96-98. 被引量:40
  • 4冯寿全,张胜华.以肝圆韧带为标志左肝管显露术的应用性研究[J].肝胆胰外科杂志,2006,18(1):35-38. 被引量:2
  • 5王耀东,李立帜,田毅峰,赖智德.腹腔镜规则性左肝外侧叶切除术15例[J].中国微创外科杂志,2007,7(1):15-16. 被引量:11
  • 6Nguyen KT, Marsh JW, Tsung A, et al. Comparative benefits of laparoscopic vs. open hepatic resection [ J ]. Arch Surg, 2011, 146(3): 348-356.
  • 7[shizawa T, Gumbs AA, Kokudo N, et al. Laparoscopic seg- Jentectomy of the liver: from segment I to V$ [J]. Ann Surg, 2012, 256(6): 959-964.
  • 8Buell JF, Cherqui D, Geller DA, et al. The international posi- tion on laparoscopie liver surgery: The Louisville Statement, '.2008 [J]. Ann Surg, 2009, 250(5): 825-830.
  • 9Tzanis D, Shivathirthan N, Laurent A, et al. European experi- ence of laparoseopie major hepateetomy [JJ. J Hepatobiliary Pancreat Sci, 2012 Oct 2. [Epub ahead of print].
  • 10Vigano L, Laurent A, Tayar C, et al. The learning curve in laparoscopic liver resection: improved feasibility and reproduc- ibility [J]. Ann Surg, 2009, 250(5): 772-782.

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部